Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Chouaid (Créteil, France), N. Germain (Paris, France), G. De Pouvourville (Cergy-Pontoise, France), S. Aballéa (Paris, France), D. Korchagina (Paris, France), M. Baldwin (Ingelheim, Germany), K. Le Lay (Paris, France), L. Luciani (Paris, France), P. Devillier (Paris, France). Patient preference for COPD treatment inhalers: A Discrete Choice Experiment (DCE) in France – Results of a Pilot Study. 3156

Member's Comments

No comment yet.

Related content which might interest you: The EDUCA (Elderly and Device Use in Chronic Asthma) multicentre Italian study on the assessment of errors and satisfaction in using the inhalers in elderly asthmatics: Preliminary results. Source: International Congress 2017 – Inhalers and their use Year: 2017 Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Safety and Feasibility of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD: 9 Month Results. Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news Year: 2019 The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Efficacy across multiple COPD endpoints over time Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 (in)Appropriate LAMA Prescribing in Asthma patients: a Cohort Analysis (the ALPACA study) Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Safety, Tolerability (S&T) and Pharmacokinetics (PK) of Single and Repeat Inhaled Doses of Phosphoinositide-3-Kinase Delta Inhibitor (PI3Kd) GSK2269557, Delivered via the ELLIPTATM Device to Healthy Subjects in a Phase I Trial, Including Charcoal Block. Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017 Automated Tele-Monitoring on CPAP Adherence at 1 Year: The Tele-OSA Trial Source: International Congress 2017 – CPAP therapy Year: 2017 Asthma Control and the Influence of Valved Holding Chamber (VHC) Type: Results from a Real World, Retrospective Study Source: International Congress 2017 – Bronchial asthma management Year: 2017 The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Consistent benefit across multiple exacerbation endpoints Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Control of asthma, adherence to inhaled therapy and usefulness of the Test of Adherence to Inhalers (TAI). Results of the ASCONA study Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017 Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Analysis of comorbidities and treatment patterns by GOLD 2013 criteria: Pooled data from Phase III aclidinium bromide studies Source: International Congress 2014 – Asthma and COPD management Year: 2014 Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT) Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS) Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 No differences? Aerosol characteristics of 9 jet nebulisers tested in vitro Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Patient and Public Involvement (PPI) in TANDEM: A Tailored intervention for ANxiety and DEpression Management in COPD Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on a Functional Respiratory Imaging (FRI) Model Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence Year: 2021 Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019